Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypoglycorrhachia: Unravelling the Pathogenetic Mechanisms.

Indian pediatrics·2025
Same author

Childhood Status Epilepticus: Current Status and Future Directions.

Indian pediatrics·2020
Same author

Association of Child Neurology-Indian Epilepsy Society Consensus Document on Parental Counseling of Children with Epilepsy.

Indian journal of pediatrics·2019
Same author

Neurodevelopmental disorders in children aged 2-9 years: Population-based burden estimates across five regions in India.

PLoS medicine·2018
Same author

Autism - Experiences in a tertiary care hospital.

Indian journal of pediatrics·2017
Same author

Consensus Statement of the Indian Academy of Pediatrics on Evaluation and Management of Attention Deficit Hyperactivity Disorder.

Indian pediatrics·2017
Same journal

Community-Acquired Pneumonia in Young Children: Variables Associated With Emergency Department Attendance and Hospitalization.

International journal of pediatrics·2026
Same journal

Quality Improvement Initiatives in Pediatric Emergency Care in Low-Resource Settings: Addressing Patient Safety and Outcomes.

International journal of pediatrics·2026
Same journal

Shifts in Pediatric Respiratory Virus Trends After the COVID-19 Pandemic: Insights From a 12-Year Hospital-Based Study in South Korea.

International journal of pediatrics·2026
Same journal

Incidence of Recurrent Otitis Media With Effusion (OME) Following Tympanostomy in Pediatric Patients: A Systematic Review and Cumulative Meta-Analysis.

International journal of pediatrics·2026
Same journal

Outcomes of Noninvasive Positive Pressure Ventilation via RAM Cannula in Pediatric Intensive Care: A Preliminary Report.

International journal of pediatrics·2026
Same journal

Seventy-Two-Hour Emergency Department Revisits in the Pediatric Population at King Abdullah Specialist Children's Hospital, Riyadh, Saudi Arabia: A Morbidity Analysis.

International journal of pediatrics·2026
See all related articles

Related Experiment Video

Updated: Jun 17, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

Pediatric migraine.

Ubaid Hameed Shah1, Veena Kalra

  • 1Apollo Centre for Advanced Pediatrics, Indraprastha Apollo Hospital, New Delhi, India.

International Journal of Pediatrics
|December 31, 2009
PubMed
Summary
This summary is machine-generated.

Pediatric migraine, a common headache disorder, is increasingly understood as a neuroinflammatory condition. Current treatments include acetaminophen and ibuprofen for acute attacks, with antiepileptic drugs showing promise for prophylaxis.

More Related Videos

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
07:01

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

Related Experiment Videos

Last Updated: Jun 17, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
07:01

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

Area of Science:

  • Pediatric Neurology
  • Neuroinflammation
  • Headache Disorders

Background:

  • Migraine is a leading cause of recurrent headaches in children.
  • Understanding of migraine pathophysiology has shifted from vascular to neuroinflammatory concepts.
  • Clinical evaluation and family history are crucial for diagnosis.

Purpose of the Study:

  • To review current understanding and management of pediatric migraine.
  • To discuss the role of established and emerging pharmacotherapies.
  • To highlight non-medicinal treatment options.

Main Methods:

  • Literature review of pediatric migraine treatment and prophylaxis.
  • Analysis of clinical trial data for new migraine drugs.
  • Evaluation of diagnostic criteria and supportive therapies.

Main Results:

  • Acetaminophen and ibuprofen are recommended for acute pediatric migraine attacks.
  • Antiepileptic drugs (AEDs) are increasingly used for migraine prophylaxis in children.
  • Limited data exists for newer migraine drugs, but AEDs show promise.
  • Non-medicinal therapies like biofeedback demonstrate positive outcomes.

Conclusions:

  • Pediatric migraine management involves acute symptom control and preventive strategies.
  • Prophylaxis decisions should consider attack frequency and impact on quality of life.
  • Emerging pharmacologic and non-pharmacologic options offer new hope for managing childhood migraine.